Search research articles
Contact Us
Filters
Showing results (71-80 of 92) with videos related to
Page
of 10
Sort By:
HPB : the Official Journal of the International Hepato Pancreato Biliary Association
|
November 19, 2024
Adjunct mucin biomarkers MUC2+MUC5AC and MUC5AC+PSCA in a clinical setting identify and may improve correct selection of high-risk pancreatic lesions for surgery
Eva Philipson, Karolina Jabbar, Svein-Olav Bratlie, et al.
Oncology Letters
|
December 20, 2024
Intratumoural expression of dihydropyrimidine dehydrogenase is an independent prognostic factor in resected pancreatic ductal adenocarcinoma treated with adjuvant gemcitabine
Hakon Blomstrand, Malin Bodarve, Fredrik Groth, et al.
Journal of Clinical Pharmacology
|
July 3, 2002
Pharmacokinetics of histamine dihydrochloride in healthy volunteers and cancer patients: implications for combined immunotherapy with interleukin-2
Mark Middleton, Mark Sarno, Sanjiv S Agarwala, et al.
Cancer Research Communications
|
April 10, 2024
Impact of Surgery-Induced Myeloid-derived Suppressor Cells and the NOX2/ROS Axis on Postoperative Survival in Human Pancreatic Cancer
Hanna Grauers Wiktorin, Ebru Aydin, Roberta Kiffin, et al.
Annals of Surgical Oncology
|
July 14, 2026
Prognostic Value of Intratumoral Expression of Claudin 18.2 in Resected Pancreatic Cancer
Jun Yoshino, Hakon Blomstrand, Sebastian Fjellander, et al.
Oncotarget
|
September 18, 2014
Melanoma patient-derived xenografts accurately model the disease and develop fast enough to guide treatment decisions
Berglind O Einarsdottir, Roger Olofsson Bagge, Joydeep Bhadury, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 5, 2002
Results from a randomized phase III study comparing combined treatment with histamine dihydrochloride plus interleukin-2 versus interleukin-2 alone in patients with metastatic melanoma
Sanjiv S Agarwala, John Glaspy, Steven J O'Day, et al.
Critical Reviews in Oncology/Hematology
|
March 11, 2020
ECCO Essential Requirements for Quality Cancer Care: Prostate cancer
Maurizio Brausi, Peter Hoskin, Elisabeth Andritsch, et al.
Journal of Cancer Policy
|
May 13, 2022
The European Code of Cancer Practice
Mark Lawler, Kathy Oliver, Stefan Gijssels, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 11, 2017
Identifying critical steps towards improved access to innovation in cancer care: a European CanCer Organisation position paper
Matti Aapro, Alain Astier, Riccardo Audisio, et al.
Page
of 10
Search research articles
Search
Showing results (71-80 of 92) with videos related to
Sort By:
Page
of 10
HPB : the Official Journal of the International Hepato Pancreato Biliary Association
|
November 19, 2024
Adjunct mucin biomarkers MUC2+MUC5AC and MUC5AC+PSCA in a clinical setting identify and may improve correct selection of high-risk pancreatic lesions for surgery
Eva Philipson, Karolina Jabbar, Svein-Olav Bratlie, et al.
Oncology Letters
|
December 20, 2024
Intratumoural expression of dihydropyrimidine dehydrogenase is an independent prognostic factor in resected pancreatic ductal adenocarcinoma treated with adjuvant gemcitabine
Hakon Blomstrand, Malin Bodarve, Fredrik Groth, et al.
Journal of Clinical Pharmacology
|
July 3, 2002
Pharmacokinetics of histamine dihydrochloride in healthy volunteers and cancer patients: implications for combined immunotherapy with interleukin-2
Mark Middleton, Mark Sarno, Sanjiv S Agarwala, et al.
Cancer Research Communications
|
April 10, 2024
Impact of Surgery-Induced Myeloid-derived Suppressor Cells and the NOX2/ROS Axis on Postoperative Survival in Human Pancreatic Cancer
Hanna Grauers Wiktorin, Ebru Aydin, Roberta Kiffin, et al.
Annals of Surgical Oncology
|
July 14, 2026
Prognostic Value of Intratumoral Expression of Claudin 18.2 in Resected Pancreatic Cancer
Jun Yoshino, Hakon Blomstrand, Sebastian Fjellander, et al.
Oncotarget
|
September 18, 2014
Melanoma patient-derived xenografts accurately model the disease and develop fast enough to guide treatment decisions
Berglind O Einarsdottir, Roger Olofsson Bagge, Joydeep Bhadury, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 5, 2002
Results from a randomized phase III study comparing combined treatment with histamine dihydrochloride plus interleukin-2 versus interleukin-2 alone in patients with metastatic melanoma
Sanjiv S Agarwala, John Glaspy, Steven J O'Day, et al.
Critical Reviews in Oncology/Hematology
|
March 11, 2020
ECCO Essential Requirements for Quality Cancer Care: Prostate cancer
Maurizio Brausi, Peter Hoskin, Elisabeth Andritsch, et al.
Journal of Cancer Policy
|
May 13, 2022
The European Code of Cancer Practice
Mark Lawler, Kathy Oliver, Stefan Gijssels, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 11, 2017
Identifying critical steps towards improved access to innovation in cancer care: a European CanCer Organisation position paper
Matti Aapro, Alain Astier, Riccardo Audisio, et al.
Page
of 10